Trial Profile
Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2012
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 16 Jan 2012 New trial record